Generic Drugs

Low copay generics improve medication use over 20%

Published in Health Insurance Week, December 31st, 2006

Patients are much more likely to continue drug therapy if their copays are low, according to two recent studies from Prime Therapeutics.

The studies, involving cholesterol-lowering statins and antihypertensives, show pharmacy benefit designs encouraging the use of low-cost generics can have a significant impact on keeping members on their medications. In turn, based on existing medical literature in these drug classes, improved medication compliance supports healthier outcomes and reduces overall health plan costs.

The two studies examined the relationship between medication use and pharmacy benefit design. Prime's studies found that decreased member...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health Insurance Week

Source: Health Insurance Week (2006-12-31)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry